Inventor · disambiguated record
Christine Edwards
Also filed as: EDWARDS CHRISTINE
17 granted patents·10 pending applications·14 citations·filing 2005–2021
88Inventor score
Top patents by PatentIndex Score
27 records- 0182US9023855B2CompoundsCHIESI FARMA SPA·Filed 2014·Granted May 5, 2015·2 cites·20 claims
- 0279US8691826B2CompoundsBLENCH TOBY JONATHAN·Filed 2012·Granted Apr 8, 2014·5 cites·17 claims
- 0373US9873709B2Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2017·Granted Jan 23, 2018·1 cites·14 claims
- 0468US8198288B2Tetrahydropyrrolopyrimidinediones and their use in therapyRAY NICHOLAS CHARLES·Filed 2008·Granted Jun 12, 2012·2 cites·14 claims
- 0566US8957082B2Tetrahydropyrrolopyrimidinediones and their use in therapyRAY NICHOLAS CHARLES·Filed 2012·Granted Feb 17, 2015·2 cites·1 claims
- 0664US10954236B2Tyrosine amide derivatives as Rho-Kinase inhibitorsCHIESI FARM SPA·Filed 2019·Granted Mar 23, 2021·0 cites·15 claims
- 0763US9156844B2Pyrimidine derivatives and their use in the treatment of respiratory diseases such a COPDEDWARDS CHRISTINE·Filed 2011·Granted Oct 13, 2015·1 cites·12 claims
- 0863US9120802B2Pyrimidine derivatives and their use in the treatment of respiratory diseases such as COPDEDWARDS CHRISTINE·Filed 2011·Granted Sep 1, 2015·1 cites·9 claims
- 0960US2019233441A1Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 1057US2018298033A1Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 1157US2024092790A1Dihydrofuropyridine derivatives as rho- kinase inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 1257US2024092791A1Dihydrofuropyridine derivatives as rho-kinase inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 1354US10501461B2Tyrosine amide derivatives as Rho-kinase inhibitorsCHIESI FARM SPA·Filed 2018·Granted Dec 10, 2019·0 cites·14 claims
- 1452US2016185780A1Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2016·Application pending·0 cites
- 1551US2021284639A1Tyrosine amide derivatives as rho- kinase inhibitorsCHIESI FARM SPA·Filed 2019·Application pending·0 cites
- 1650US7902224B2Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulatorsGLAXO GROUP LTD·Filed 2005·Granted Mar 8, 2011·0 cites·20 claims
- 1750US2024082223A1Dihydrofuropyridine derivatives as rho- kinase inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 1848US11725007B2Meta tyrosine derivatives as rho-kinase inhibitorsCHIESI FARM SPA·Filed 2018·Granted Aug 15, 2023·0 cites·13 claims
- 1946US11578068B2Oxadiazole derivatives as Rho-Kinase InhibitorsCHIESI FARM SPA·Filed 2018·Granted Feb 14, 2023·0 cites·23 claims
- 2046US11147812B2Tyrosine analogues derivatives as Rho-kinase inhibitorsCHIESI FARM SPA·Filed 2018·Granted Oct 19, 2021·0 cites·14 claims
- 2145US10584128B2Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-Kinase inhibitorsCHIESI FARM SPA·Filed 2017·Granted Mar 10, 2020·0 cites·14 claims
- 2244US2021253568A1Azaindole derivatives as rho-kinase inhibitorsCHIESI FARM SPA·Filed 2019·Application pending·0 cites
- 2343US2009105268A1Dihydropyrimidone Multimers and Their Use as Human Neutrophil, Elastase InhibitorsFINCH HARRY·Filed 2006·Application pending·0 cites
- 2442US11332468B2Azaindole derivatives as Rho-kinase inhibitorsCHIESI FARM SPA·Filed 2018·Granted May 17, 2022·0 cites·15 claims
- 2539US2009111795A1Multimers of Heterocyclic Compounds and Their UseFINCH HARRY·Filed 2006·Application pending·0 cites
- 2638US8501780B2Indazole carboxamides and their useKERNS JEFFREY K·Filed 2005·Granted Aug 6, 2013·0 cites·5 claims
- 2735US8455505B2Pyrrolopyrimidinedione and its therapeutic useEDWARDS CHRISTINE·Filed 2010·Granted Jun 4, 2013·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Christine Edwards files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →